Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
After finishing at $22.12 in the prior trading day, Exelixis Inc (NASDAQ: EXEL) closed at $21.90, down -0.99%. In other words, the price has decreased by -$0.99 from its previous closing price. On the day, 2.48 million shares were traded. EXEL stock price reached its highest trading level at $22.47 during the session, while it also had its lowest trading level at $21.732.
Ratios:
Our goal is to gain a better understanding of EXEL by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 6.62 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 22.82. For the most recent quarter (mrq), Quick Ratio is recorded 3.41 and its Current Ratio is at 3.46. In the meantime, Its Debt-to-Equity ratio is 0.09 whereas as Long-Term Debt/Eq ratio is at 0.09.
On December 19, 2023, BTIG Research started tracking the stock assigning a Buy rating and target price of $27.
On December 15, 2023, Citigroup started tracking the stock assigning a Buy rating and target price of $31.Citigroup initiated its Buy rating on December 15, 2023, with a $31 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 21 ’24 when Garber Alan M sold 19,205 shares for $24.01 per share. The transaction valued at 461,112 led to the insider holds 35,703 shares of the business.
Haley Patrick J. sold 47,020 shares of EXEL for $1,008,579 on Feb 23 ’24. The EVP, Commercial now owns 384,866 shares after completing the transaction at $21.45 per share. On Feb 21 ’24, another insider, JOHNSON DAVID EDWARD, who serves as the Director of the company, bought 190,000 shares for $20.70 each. As a result, the insider paid 3,932,734 and bolstered with 1,100,730 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, EXEL now has a Market Capitalization of 6379316224 and an Enterprise Value of 5617520128. As of this moment, Exelixis’s Price-to-Earnings (P/E) ratio for their current fiscal year is 33.87, and their Forward P/E ratio for the next fiscal year is 14.42. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.78. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.45 while its Price-to-Book (P/B) ratio in mrq is 3.04. Its current Enterprise Value per Revenue stands at 3.042 whereas that against EBITDA is 24.467.
Stock Price History:
Over the past 52 weeks, EXEL has reached a high of $24.34, while it has fallen to a 52-week low of $18.52. The 50-Day Moving Average of the stock is -4.41%, while the 200-Day Moving Average is calculated to be -0.16%.
Shares Statistics:
The stock has traded on average 2.36M shares per day over the past 3-months and 2491480 shares per day over the last 10 days, according to various share statistics. A total of 302.79M shares are outstanding, with a floating share count of 283.24M. Insiders hold about 2.76% of the company’s shares, while institutions hold 90.10% stake in the company. Shares short for EXEL as of 1713139200 were 8624543 with a Short Ratio of 3.65, compared to 1710460800 on 8254189. Therefore, it implies a Short% of Shares Outstanding of 8624543 and a Short% of Float of 3.8900003.
